Abstract:Although computational predictions of pharmacokinetics (PK) are desirable at the drug design stage, existing approaches are often limited by prediction accuracy and human interpretability. Using a discovery data set of mouse and rat PK studies at Roche (9,685 unique compounds), we performed a proof-of-concept study to predict key PK properties from chemical structure alone, including plasma clearance (CLp), volume of distribution at steady-state (Vss), and oral bioavailability (F). Ten machine learning (ML) models were evaluated, including Single-Task, Multitask, and transfer learning approaches (i.e., pretraining with in vitro data). In addition to prediction accuracy, we emphasized human interpretability of outcomes, especially the quantification of uncertainty, applicability domains, and explanations of predictions in terms of molecular features. Results show that intravenous (IV) PK properties (CLp and Vss) can be predicted with good precision (average absolute fold error, AAFE of 1.96-2.84 depending on data split) and low bias (average fold error, AFE of 0.98-1.36), with AutoGluon, Gaussian Process Regressor (GP), and ChemProp displaying the best performance. Driven by higher complexity of oral PK studies, predictions of F were more challenging, with the best AAFE values of 2.35-2.60 and higher overprediction bias (AFE of 1.45-1.62). Multi-Task approaches and pretraining of ChemProp neural networks with in vitro data showed similar precision to Single-Task models but helped reduce the bias and increase correlations between observations and predictions. A combination of GP-computed prediction variance, molecular clustering, and dimensionality-reduction provided valuable quantitative insights into prediction uncertainty and applicability domains. SHAPley Additive exPlanations (SHAPs) highlighted molecular features contributing to prediction outcomes of Vss, providing explanations that could aid drug design. Combined results show that computational predictions of PK are feasible at the drug design stage, with several ML technologies converging to successfully leverage historical PK data sets. Further studies are needed to unlock the full potential of this approach, especially with respect to data set sizes and quality, transfer learning between in vitro and in vivo data sets, model-independent quantification of uncertainty, and explainability of predictions.

Prediction method of pharmacokinetic parameters of small molecule drugs based on GCN network model

A Novel Strategy for Prediction of Human Plasma Protein Binding Using Machine Learning Techniques

Quantitative Structure-Pharmacokinetic Relationships for Drug Distribution Properties by Using General Regression Neural Network.

A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans

A Machine Learning-Based Biological Drug–Target Interaction Prediction Method for a Tripartite Heterogeneous Network

Drug-Target Interaction Prediction Based on Graph Neural Network and Recommendation System

Prediction of drug protein interactions based on variable scale characteristic pyramid convolution network

GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores

Microbe-drug association prediction model based on graph convolution and attention networks

An Integrated Transfer Learning and Multitask Learning Approach for Pharmacokinetic Parameter Prediction

NGCN : Drug‐target interaction prediction by integrating information and feature learning from heterogeneous network

Accurate predictions of aqueous solubility of drug molecules via the multilevel graph convolutional network (MGCN) and SchNet architectures

Computational Predictions of Nonclinical Pharmacokinetics at the Drug Design Stage

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

SMGCN: Multiple Similarity and Multiple Kernel Fusion Based Graph Convolutional Neural Network for Drug-Target Interactions Prediction.

Predicting associations between drugs and G protein-coupled receptors using a multi-graph convolutional network

Using Compound Similarity and Functional Domain Composition for Prediction of Drug-Target Interaction Networks.

Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules

Introduction of an artificial neural network–based method for concentration‐time predictions

A Deep Neural Network -- Mechanistic Hybrid Model to Predict Pharmacokinetics in Rat

SS-GNN: A Simple-Structured Graph Neural Network for Affinity Prediction